Organon is a global healthcare company formed following a spinoff from Merck (known as MSD outside of the U.S. and Canada) to focus on improving the health of women throughout their lives. The company serves 140 markets with a portfolio of more than 60 medicines and products across its three pillars—women’s health, biosimilars and established therapeutic areas. 

Keen to shift the focus of women’s healthcare beyond female reproduction to unaddressed needs, Organon is the only global company of its size focused on women’s health. With a vision to create a better and healthier every day for women in line with the UN Sustainable Development Goals for gender equality and female empowerment, Organon’s mission is to improve and innovate across the women’s healthcare space.